PharmaCyte Biotech, Inc. Contracts & Agreements

96 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Consulting Agreement
Consulting Agreements
PharmaCyte Biotech, Inc.
Biotechnology
MD
2014
Securities Purchase Agreement, dated May 20, by and among PharmaCyte Biotech, Inc. and MyMD Pharmaceuticals, Inc
Purchase Agreements
PharmaCyte Biotech, Inc.
2024
Form of Certificate of Designations of Series G Convertible Preferred Stock of MyMD Pharmaceuticals, Inc
Stock Agreements
PharmaCyte Biotech, Inc.
2024
Form of Long-Term Warrant of MyMD Pharmaceuticals, Inc
Warrant Agreements
PharmaCyte Biotech, Inc.
2024
Form of Short-Term Warrant of MyMD Pharmaceuticals, Inc
Warrant Agreements
PharmaCyte Biotech, Inc.
2024
Registration Rights Agreement, dated May 20, by and among PharmaCyte Biotech, Inc. and MyMD Pharmaceuticals, Inc
Registration Rights Agreements
PharmaCyte Biotech, Inc.
2024
Form of Series A Warrant
Warrant Agreements
PharmaCyte Biotech, Inc.
2023
Form of Series B Warrant
Warrant Agreements
PharmaCyte Biotech, Inc.
2023
Form of Purchase Agreement
Purchase Agreements
PharmaCyte Biotech, Inc.
2023
Form of Convertible Note
Note Agreements
PharmaCyte Biotech, Inc.
2023
Form of Registration Rights Agreement
Registration Rights Agreements
PharmaCyte Biotech, Inc.
2023
Form of Collaboration Agreement
Collaboration Agreements
PharmaCyte Biotech, Inc.
2023
Form of Warrant
Warrant Agreements
PharmaCyte Biotech, Inc.
2023
Form of Purchase Agreement
Purchase Agreements
PharmaCyte Biotech, Inc.
2023
Form of Registration Rights Agreement
Registration Rights Agreements
PharmaCyte Biotech, Inc.
2023
Engagement Letter, dated May 9, 2023 by and between Synaptogenix, Inc. and Katalyst Securities LLC
PharmaCyte Biotech, Inc.
2023
Release Agreement, dated October 12, 2022, by and between PharmaCyte Biotech, Inc. and Gerald W. Crabtree
Release Agreements
PharmaCyte Biotech, Inc.
2022
Separation, Consulting and Release Agreement, dated October 6, 2022, by and between PharmaCyte Biotech, Inc. and Kenneth L. Waggoner
Consulting Agreements
PharmaCyte Biotech, Inc.
Biotechnology
NV
2022
Cooperation Agreement dated August 15, 2022, by and between PharmaCyte Biotech, Inc. and Iroquois Master Fund Ltd. and its affiliates
Cooperation Agreements
PharmaCyte Biotech, Inc.
Biotechnology
NV
2022
Form of Director Offer Letter
PharmaCyte Biotech, Inc.
Biotechnology
NV
2022
Description of Securities
PharmaCyte Biotech, Inc.
2022
Amended and Restated Executive Compensation Agreement, dated May 8, 2022, between Kenneth L. Waggoner and the Company
Compensation Agreements
PharmaCyte Biotech, Inc.
2022
Amended and Restated Executive Compensation Agreement, dated May 8, 2022, between Carlos A. Trujillo and the Company
Compensation Agreements
PharmaCyte Biotech, Inc.
2022
PharmaCyte Biotech, Inc. 2021 Equity Incentive Plan
Bonus & Incentive Agreements
PharmaCyte Biotech, Inc.
2022
Form of Pre-Funded Common Stock Purchase Warrant
Warrant Agreements
PharmaCyte Biotech, Inc.
Biotechnology
NY
2021
Form of Series A Warrant Common Stock Purchase Warrant
Warrant Agreements
PharmaCyte Biotech, Inc.
Biotechnology
NY
2021
Form of Placement Agent Common Stock Purchase Warrant
Warrant Agreements
PharmaCyte Biotech, Inc.
2021
Securities Purchase Agreement, dated as of August 19, 2021
Purchase Agreements
PharmaCyte Biotech, Inc.
2021
Underwriting Agreement, dated as of August 9, 2021
Underwriting Agreements
PharmaCyte Biotech, Inc.
2021
Form of Common Warrant
Warrant Agreements
PharmaCyte Biotech, Inc.
2021
Form of Pre-funded Warrant
Warrant Agreements
PharmaCyte Biotech, Inc.
2021
Form of Underwriters Warrant
Warrant Agreements
PharmaCyte Biotech, Inc.
Biotechnology
NY
2021
Description of Securities
PharmaCyte Biotech, Inc.
Biotechnology
2021
Amendment No. 3, dated as of October 14, 2020, to Executive Compensation Agreement between Gerald W. Crabtree and the Company
Compensation Agreements
PharmaCyte Biotech, Inc.
Biotechnology
2020
Right of First Refusal Agreement by and between PharmaCyte Biotech, Inc. and Silver Rock Associates, Inc., dated May 4, 2020
PharmaCyte Biotech, Inc.
Biotechnology
2020
Amendment No. 1 to Right of First Refusal Agreement by and between PharmaCyte Biotech, Inc. and Silver Rock Associates, Inc., dated July 15, 2020
PharmaCyte Biotech, Inc.
2020
Share Subscription Agreement between the Company and the Investor dated January 17, 2020
Share Agreements
PharmaCyte Biotech, Inc.
2020
Fourth Amendment to Asset Purchase Agreement between the Company, S.G. Austria Pte. Ltd. and Austrianova Singapore Pte. Ltd. effective May 14, 2018
Purchase Agreements
PharmaCyte Biotech, Inc.
2018
Third Amendment to Licensing Agreement between the Company and Austrianova Singapore Pte. Ltd. effective May 14, 2018
PharmaCyte Biotech, Inc.
Biotechnology
2018
Second Amendment to Licensing Agreement between the Company and Austrianova Singapore Pte. Ltd. effective May 14, 2018
PharmaCyte Biotech, Inc.
Biotechnology
2018
Financial Advisory, Offering and At-the-Market Offering Engagement Letter dated February 22, 2018, by and between PharmaCyte Biotech, Inc. and Aeon Capital, Inc
Advisory Agreements
PharmaCyte Biotech, Inc.
Biotechnology
2018
Mutual Termination Agreement dated January 26, 2018, by and between PharmaCyte Biotech, Inc. and Chardan Capital Markets, LLC
Termination Agreements
PharmaCyte Biotech, Inc.
Biotechnology
2018
Letter Agreement between the Company and Dr. Tong dated October 9, 2017
PharmaCyte Biotech, Inc.
2017
Binding Term Sheet between Austrianova Singapore Pte. Ltd. andSG Austria Pte. Ltd. and PharmaCyte Biotech, Inc.
Term Sheets
PharmaCyte Biotech, Inc.
2017
[Signaturepage follows]
PharmaCyte Biotech, Inc.
Biotechnology
CA
2017
[Signature page to follow]
PharmaCyte Biotech, Inc.
2017
AMENDMENT NO. 2 TO EXECUTIVE COMPENSATIONAGREEMENT
PharmaCyte Biotech, Inc.
2017
AMENDMENTNo. 2 TO executive Compensation AGREEMENT
Compensation Agreements
PharmaCyte Biotech, Inc.
2017
AMENDMENT NO. 2 TO EXECUTIVECOMPENSATION AGREEMENT
PharmaCyte Biotech, Inc.
Biotechnology
NV
2017
FOURTHSTOCK OPTION AGREEMENT
PharmaCyte Biotech, Inc.
2017
ThirdSTOCK OPTION AGREEMENT
PharmaCyte Biotech, Inc.
Biotechnology
NV
2017
FOURTHSTOCK OPTION AGREEMENT
PharmaCyte Biotech, Inc.
Biotechnology
NV
2017
23046 Avenida de la Carlota| Suite 600 | Laguna Hills | California 92653 Office: 917 ###-###-#### |Fax: 917 ###-###-#### | Mobile: 917 ###-###-#### | ***@***
PharmaCyte Biotech, Inc.
Biotechnology
2017
CHARDAN CAPITAL MARKETS
PharmaCyte Biotech, Inc.
Biotechnology
2016
SECOND AMENDMENT TO LICENSE AGREEMENT Relating to Encapsulated Cells Producing Viral Particles and Encapsulated Cells Expressing Biomolecules LICENSORS Bavarian Nordic A/S, reg....
License Agreements
PharmaCyte Biotech, Inc.
Biotechnology
2016
First Amendment toLicensing Agreement
PharmaCyte Biotech, Inc.
Biotechnology
2016
SecondAmendment toLicensingAgreement
PharmaCyte Biotech, Inc.
Biotechnology
2016
First Amendmentto Licensing Agreement
PharmaCyte Biotech, Inc.
2016
BINDING MEMORANDUM OF UNDERSTANDING
MOUs
PharmaCyte Biotech, Inc.
Biotechnology
2016
AMENDMENT NO. 1 TO EXECUTIVE COMPENSATIONAGREEMENT
PharmaCyte Biotech, Inc.
Biotechnology
2016
AMENDMENT NO. 1 TO EXECUTIVE COMPENSATIONAGREEMENT
PharmaCyte Biotech, Inc.
Biotechnology
2016
THIRD STOCK OPTION AGREEMENT
Stock Agreements
PharmaCyte Biotech, Inc.
Biotechnology
NV
2016
THIRD STOCK OPTION AGREEMENT
Stock Agreements
PharmaCyte Biotech, Inc.
2016
PHARMACYTE BIOTECH, INC. COMMON STOCK WARRANT AGREEMENT
Warrant Agreements
PharmaCyte Biotech, Inc.
Biotechnology
2016
PHARMACYTE BIOTECH, INC. COMMON STOCK WARRANT AGREEMENT
Warrant Agreements
PharmaCyte Biotech, Inc.
Biotechnology
2016
STOCK AND WARRANT PURCHASE AGREEMENT
Warrant Agreements
PharmaCyte Biotech, Inc.
2016
STOCK AND WARRANT PURCHASE AGREEMENT
Warrant Agreements
PharmaCyte Biotech, Inc.
2016
12510 Prosperity Drive | Suite 310 | SilverSpring | Maryland 20904-1643 Office: 917 ###-###-#### | Fax: 917 ###-###-####| Mobile: 917 ###-###-#### | ***@***
PharmaCyte Biotech, Inc.
2015
ExecutiveCompensation AGREEMENT
PharmaCyte Biotech, Inc.
2015
FIRST stock option agreement
Stock Agreements
PharmaCyte Biotech, Inc.
Biotechnology
NV
2015
SECOND stock option agreement
Stock Agreements
PharmaCyte Biotech, Inc.
Biotechnology
NV
2015
ExecutiveCompensation AGREEMENT
PharmaCyte Biotech, Inc.
2015
FIRST stock option agreement
Stock Agreements
PharmaCyte Biotech, Inc.
2015
Second stock option agreement
Stock Agreements
PharmaCyte Biotech, Inc.
2015
Licensing Agreement
PharmaCyte Biotech, Inc.
2014
Consulting Agreement
Consulting Agreements
PharmaCyte Biotech, Inc.
Biotechnology
MD
2014
stock option agreement
Stock Agreements
PharmaCyte Biotech, Inc.
2014
stock option agreement
Stock Agreements
PharmaCyte Biotech, Inc.
2014
Consulting Agreement
Consulting Agreements
PharmaCyte Biotech, Inc.
2014
stock option agreement
Stock Agreements
PharmaCyte Biotech, Inc.
Biotechnology
NY
2014
SETTLEMENT AGREEMENT
Settlement Agreements
PharmaCyte Biotech, Inc.
Biotechnology
MD
2014
ASSET PURCHASE AGREEMENT
Purchase Agreements
PharmaCyte Biotech, Inc.
2014
MEMORANDUM OF UNDERSTANDING
MOUs
PharmaCyte Biotech, Inc.
Biotechnology
2014
EMPLOYMENT AGREEMENT
Employment Agreements
PharmaCyte Biotech, Inc.
2014
LICENSE AGREEMENT Relating to Encapsulated Cells Producing Viral Particles and Encapsulated Cells Expressing Biomolecules LICENSORS BAVARIAN NORDIC A/S, reg. no.16271187, a...
License Agreements
PharmaCyte Biotech, Inc.
Biotechnology
2014
AMENDMENT TO LICENSE AGREEMENT Relating to Encapsulated Cells Producing Viral Particles and Encapsulated Cells Expressing Biomolecules LICENSORS BAVARIAN NORDIC A/S, reg....
License Agreements
PharmaCyte Biotech, Inc.
Biotechnology
2014
MANUFACTURING FRAMEWORK AGREEMENT
PharmaCyte Biotech, Inc.
2014
MASTER SERVICES AGREEMENT
Services Agreements
PharmaCyte Biotech, Inc.
2014
CONSULTING AGREEMENT
Consulting Agreements
PharmaCyte Biotech, Inc.
Biotechnology
2014
MASTER CONSULTANCY AGREEMENT Between Nuvilex, Inc. And BB Biotech Consulting GmbH
Consulting Agreements
PharmaCyte Biotech, Inc.
Biotechnology
2014
MUTUAL TERMINATION AND RELEASE AGREEMENT
Termination Agreements
PharmaCyte Biotech, Inc.
2014
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreements
PharmaCyte Biotech, Inc.
2014
PURCHASE AGREEMENT
Purchase Agreements
PharmaCyte Biotech, Inc.
2014
THIRD ADDENDUM TO ASSET PURCHASE AGREEMENT By and Between Nuvilex, Inc. (NVLX) And SG Austria Private Limited (SGA) Effective As Of June 25, 2013 THIRD ADDENDUM TO ASSET PURCHASE...
Purchase Agreements
PharmaCyte Biotech, Inc.
2013
Licensing Agreement
PharmaCyte Biotech, Inc.
Biotechnology
2013
REAL ESTATE SALE AGREEMENT
PharmaCyte Biotech, Inc.
2010